A detailed history of Seelaus Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Seelaus Asset Management LLC holds 11,553 shares of BMY stock, worth $672,731. This represents 0.58% of its overall portfolio holdings.

Number of Shares
11,553
Previous 11,633 0.69%
Holding current value
$672,731
Previous $483,000 23.6%
% of portfolio
0.58%
Previous 0.52%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$39.66 - $51.75 $3,172 - $4,140
-80 Reduced 0.69%
11,553 $597,000
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $160,154 - $210,847
-3,979 Reduced 25.49%
11,633 $483,000
Q1 2024

May 01, 2024

SELL
$47.98 - $54.4 $76,720 - $86,985
-1,599 Reduced 9.29%
15,612 $846,000
Q4 2023

Jan 26, 2024

SELL
$48.48 - $57.85 $79,992 - $95,452
-1,650 Reduced 8.75%
17,211 $883,000
Q3 2023

Nov 16, 2023

SELL
$57.89 - $64.73 $61,884 - $69,196
-1,069 Reduced 5.36%
18,861 $1.09 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $546,950 - $607,302
-8,585 Reduced 30.11%
19,930 $1.28 Million
Q1 2023

Apr 19, 2023

SELL
$65.71 - $74.53 $208,629 - $236,632
-3,175 Reduced 10.02%
28,515 $2 Million
Q4 2022

Jan 19, 2023

SELL
$68.48 - $81.09 $23,625 - $27,976
-345 Reduced 1.08%
31,690 $2.28 Million
Q3 2022

Oct 11, 2022

SELL
$0.13 - $76.84 $26 - $15,368
-200 Reduced 0.62%
32,035 $2.28 Million
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $39,868 - $43,909
-549 Reduced 1.67%
32,235 $2.48 Million
Q1 2022

Apr 13, 2022

SELL
$61.48 - $73.72 $63,324 - $75,931
-1,030 Reduced 3.05%
32,784 $2.39 Million
Q4 2021

Jan 10, 2022

SELL
$53.63 - $62.52 $428,342 - $499,347
-7,987 Reduced 19.11%
33,814 $2.11 Million
Q3 2021

Oct 19, 2021

SELL
$59.17 - $69.31 $22,780 - $26,684
-385 Reduced 0.91%
41,801 $2.47 Million
Q2 2021

Jul 27, 2021

SELL
$61.91 - $67.42 $465,996 - $507,470
-7,527 Reduced 15.14%
42,186 $2.82 Million
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $63,909 - $71,878
1,077 Added 2.21%
49,713 $3.14 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $67,671 - $76,683
1,172 Added 2.47%
48,636 $3.02 Million
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $70,466 - $78,086
-1,227 Reduced 2.52%
47,464 $2.86 Million
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $71,375 - $83,445
1,302 Added 2.75%
48,691 $2.86 Million
Q1 2020

May 04, 2020

BUY
$46.4 - $67.43 $68,718 - $99,863
1,481 Added 3.23%
47,389 $2.64 Million
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $1.79 Million - $2.34 Million
36,458 Added 385.8%
45,908 $2.95 Million
Q3 2019

Nov 08, 2019

SELL
$42.77 - $50.71 $17,108 - $20,284
-400 Reduced 4.06%
9,450 $479,000
Q2 2019

Jul 31, 2019

BUY
$44.62 - $49.34 $8,924 - $9,868
200 Added 2.07%
9,850 $447,000
Q1 2019

May 06, 2019

SELL
$45.12 - $53.8 $6,768 - $8,070
-150 Reduced 1.53%
9,650 $460,000
Q4 2018

Feb 08, 2019

BUY
$48.76 - $63.23 $7,314 - $9,484
150 Added 1.55%
9,800 $509,000
Q1 2018

May 07, 2018

BUY
$59.92 - $68.98 $38,948 - $44,837
650 Added 7.22%
9,650 $610,000
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $539,460 - $588,150
9,000
9,000 $552,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Seelaus Asset Management LLC Portfolio

Follow Seelaus Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seelaus Asset Management LLC with notifications on news.